Physician profile
Padma M Aking
NPI 1700975893
$43,938.58
in general payments reported to CMS, 2019-2025
7 companies · $8,963 in 2025
The $8,963 reported for 2025 was more than what 95% of Psychiatry providers received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $475 · 2020: $159 · 2021: $75.21 · 2022: $291 · 2023: $18K · 2024: $16K · 2025: $8,963.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $38K · Travel and Lodging: $3,089 · Food and Beverage: $1,900 · Consulting Fee: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $37,750.00 |
| Travel and Lodging | $3,088.93 |
| Food and Beverage | $1,899.72 |
| Consulting Fee | $200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $43,040.92 | 2019-2025 | Spravato, Invega Sustenna |
| Janssen Scientific Affairs, LLC | $343.72 | 2023-2025 | Spravato |
| Sunovion Pharmaceuticals INC. | $239.43 | 2019-2020 | |
| Boston Scientific Corporation | $137.96 | 2024 | |
| Axsome Therapeutics, INC. | $125.00 | 2023 | Auvelity |
| Alkermes, INC. | $29.20 | 2025 | Aristada, Lybalvi |
| Abbott Laboratories | $22.35 | 2025 | Freestyle Libre 3 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Padma Aking listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.